clinical pharmacology study of K-877
Phase 1
- Conditions
- Dyslipidemia
- Registration Number
- JPRN-jRCT2080222360
- Lead Sponsor
- Kowa Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Dyslipidemia
Exclusion Criteria
The subject who need to be taken prohibited concomitant medication
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Parameter associated lipid metabolism<br>change
- Secondary Outcome Measures
Name Time Method ipid parameters<br>percent change etc.